Virax Biolabs VRAX
NASDAQ VRAX
$1.34 -0.03 (-2.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Virax Biolabs (VRAX) Long-Term Deferred Tax (2023 - 2026)

Updated

Analysis

Virax Biolabs (VRAX) Long-Term Deferred Tax (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Virax Biolabs 536,746.51 -20.76 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 327,381.00
Sep 30, 2025 290,410.00
Mar 31, 2025 306,652.00
Sep 30, 2024 354,901.00
Mar 31, 2024 206,090.00
Sep 30, 2023 172,257.00
API Access

Virax Biolabs Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=VRAX&period=max&api_key=YOUR_API_KEY